Skip to main content
Log in

Ad26.COV2-S

Guillain-Barre syndrome following exposure during pregnancy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Moro PL, et al. Post-authorization surveillance of adverse events following COVID-19 vaccines in pregnant persons in the vaccine adverse event reporting system (VAERS), December 2020 - October 2021. Vaccine 40: 3389-3394, No. 24, 26 May 2022. Available from: URL: http://doi.org/10.1016/j.vaccine.2022.04.031

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ad26.COV2-S. Reactions Weekly 1950, 18 (2023). https://doi.org/10.1007/s40278-023-36415-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-36415-z

Navigation